Exopharm Limited
Exopharm Limited (EX1.AX) Stock Overview
Explore Exopharm Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.9M
P/E Ratio
-0.30
EPS (TTM)
$-0.09
ROE
-1.10%
EX1.AX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Exopharm Limited (EX1.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.01.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.30 and a market capitalization of 1.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.